載入...
Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Immune checkpoint blockades, such as inhibitors against programmed death 1 (PD-1) and its ligand (PD-L1), have received extensive attention in the past decade because of their dramatic clinical outcomes in advanced malignancies. However, both primary and acquired resistance becomes one of the major...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746415/ https://ncbi.nlm.nih.gov/pubmed/29299180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22690 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|